Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Bone Loss”

468 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 468 results

Not applicableStudy completedNCT04040010
What this trial is testing

The Effects of Bovine Colostrum in Bone Metabolism in Humans

Who this might be right for
OsteopeniaOsteoporosis
Petros Dinas 60
Not applicableLooking for participantsNCT06655701
What this trial is testing

Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Beylikduzu State Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00010712
What this trial is testing

Effects of Black Cohosh on Menopausal Hot Flashes

Who this might be right for
PostmenopauseHot FlashesOsteoporosis, Postmenopausal
National Center for Complementary and Integrative Health (NCCIH)
Post-approval studies (Phase 4)Study completedNCT05630768
What this trial is testing

Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

Who this might be right for
Postmenopausal Osteoporosis
Dong-A ST Co., Ltd. 149
Large-scale testing (Phase 3)Study completedNCT00543023
What this trial is testing

The Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 104
Early research (Phase 1)Ended earlyNCT01159873
What this trial is testing

Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women

Who this might be right for
Bone LossOsteoporosis
Cephalon 2
Testing effectiveness (Phase 2)Study completedNCT00532337
What this trial is testing

Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or Osteoporosis

Who this might be right for
OsteoporosisOsteopenia
Ono Pharma USA Inc 285
Testing effectiveness (Phase 2)Study completedNCT00674453
What this trial is testing

The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation

Who this might be right for
Bone Loss
Ligand Pharmaceuticals 51
Testing effectiveness (Phase 2)Study completedNCT00112437
What this trial is testing

Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)

Who this might be right for
Osteoporosis
Merck Sharp & Dohme LLC 399
Testing effectiveness (Phase 2)UnknownNCT01834105
What this trial is testing

Molecular Mechanism of POP Kidney Yin Deficiency Syndrome From the Interventional Effects of CLCF1

Who this might be right for
Postmenopausal Osteoporosis
Fujian Academy of Traditional Chinese Medicine 25
Not applicableStudy completedNCT00891553
What this trial is testing

CR9112792, a Follow-up of Study CR9108963

Who this might be right for
Osteoporosis
GlaxoSmithKline 171
Post-approval studies (Phase 4)Active Not RecruitingNCT04467983
What this trial is testing

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

Who this might be right for
Osteoporosis, Postmenopausal
Hospital for Special Surgery, New York 70
Testing effectiveness (Phase 2)Study completedNCT00238745
What this trial is testing

Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

Who this might be right for
Postmenopausal Osteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer 375
Post-approval studies (Phase 4)Study completedNCT05386784
What this trial is testing

Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia

Who this might be right for
Postemenopusal Women With Osteopenia
Yonsei University 112
Large-scale testing (Phase 3)Study completedNCT00515463
What this trial is testing

A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral Density

Who this might be right for
Low Bone Mineral DensityOsteopeniaOsteoporosis
Amgen 311
Large-scale testing (Phase 3)Study completedNCT00532207
What this trial is testing

Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Post-Menopausal
Eli Lilly and Company 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07191353
What this trial is testing

Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women

Who this might be right for
HealthyOsteopeniaOsteoporosis Risk
Odense University Hospital 148
Early research (Phase 1)Study completedNCT04747392
What this trial is testing

Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults

Who this might be right for
Postmenopausal Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd. 64
Post-approval studies (Phase 4)Study completedNCT02598934
What this trial is testing

Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 308
Post-approval studies (Phase 4)Active Not RecruitingNCT05493761
What this trial is testing

Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverOsteoporosis, Postmenopausal
Aristotle University Of Thessaloniki 72
Load More Results